EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients' questions

Ann Rheum Dis. 2022 Jun;81(6):786-788. doi: 10.1136/annrheumdis-2021-221965. Epub 2022 Feb 4.

Authors

Johannes Wj Bijlsma¹; EULAR COVID-19 Task Force

Affiliation

¹ Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands j.w.j.bijlsma@gmail.com.

PMID: 35121591
DOI: 10.1136/annrheumdis-2021-221965

No abstract available

Keywords: COVID-19; epidemiology; immune system diseases; vaccination.

MeSH terms

COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Muscular Diseases
SARS-CoV-2*
Vaccination

Substances

COVID-19 Vaccines

Supplementary concepts

Rippling muscle disease, 1